Archives of Internal Medicine · 1997 · 333 citations · 0 references
MedicineHematologyInternal MedicineDiagnostic ImagingUltrasonographyVascular SurgeryDeep Vein ThrombosisPulmonary EmbolismThromboembolic DiseaseThrombosisVenous DiseaseVenous ThromboembolismCompression UltrasonographyDeep Vein Thrombosis AssessmentDeep Vein Thrombosis DetectionPulmonary Embolism UltrasonographyRecurrent Pulmonary EmbolismThromboembolic Complication DetectionUpper Extremity Venous ThrombosisVenous Thromboembolism Diagnosis
Upper‑extremity deep vein thrombosis can arise spontaneously or as a complication of pacemaker use, long‑term central venous catheters, or cancer. The study compared demographics, symptoms, risk factors, prophylaxis, and initial management among 324 CVC‑associated UEDVT, 268 non‑CVC‑associated UEDVT, and 4796 lower‑extremity DVT patients to better understand UEDVT. The authors used a prospective multicenter DVT registry to compare the three patient groups. Non‑CVC‑associated UEDVT patients were younger, leaner, less often white, and more likely to smoke, while an indwelling CVC was the strongest independent predictor of UEDVT (OR 7.3); age < 67 yr, BMI < 25 kg/m², and hospitalization predicted non‑CVC UEDVT, yet only 20 % received prophylaxis and most were evaluated as inpatients, highlighting gaps in current understanding and prophylaxis.
Upper-extremity deep vein thrombosis (UEDVT) occurs spontaneously or sometimes develops as a complication of pacemaker use, long-term use of a central venous catheter (CVC), or cancer.To improve our understanding of UEDVT, we compared the demographics, symptoms, risk factors, prophylaxis, and initial management of 324 (6%) patients with central venous catheter (CVC)-associated UEDVT, 268 (5%) patients with non-CVC-associated UEDVT, and 4796 (89%) patients with lower-extremity DVT from a prospective US multicenter DVT registry. The non-CVC-associated UEDVT patients were younger (59.2+/-18.2 versus 64.2+/-16.9 years old; P<0.0001), less often white (65% versus 73%; P<0.01), leaner (body mass index [BMI] 26.8+/-7.1 versus 28.5+/-7.3 kg/m2; P<0.001), and more likely to smoke (19% versus 13%; P=0.02) than the lower-extremity DVT patients. By way of propensity analysis and multivariable logistic regression analysis, we determined that an indwelling CVC was the strongest independent predictor of UEDVT (odds ratio [OR], 7.3; 95% confidence interval [CI], 5.8 to 9.2). An age of <67 years, a BMI of <25 kg/m2, and hospitalization were the independent predictors of non-CVC-associated UEDVT. Most (68%) UEDVT patients were evaluated while they were inpatients. Only 20% of the 378 UEDVT patients who did not have an obvious contraindication to anticoagulation received prophylaxis at the time of diagnosis.UEDVT risk factors differ from the conventional risk factors for lower-extremity DVT. Our findings identify deficiencies in our current understanding and the prophylaxis of UEDVT and generate hypotheses for future research efforts.